Woodline Partners LP An2 Therapeutics, Inc. Transaction History

Woodline Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.51 - $19.69 $265,129 - $613,441	31,155 Added 40.92%	107,300 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$7.61 - $22.29 $237,089 - $694,444	-31,155 Reduced 29.04%	76,145 $1.32 Million
Q2 2022 Aug 15, 2022	SELL	$7.7 - $18.82 $328,790 - $803,614	-42,700 Reduced 28.47%	107,300 $832,000
Q1 2022 May 16, 2022	BUY	$15.0 - $15.4 $2.25 Million - $2.31 Million	150,000 New	150,000 $2.26 Million

7.57M

Ticker ANTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,402,700
Market Cap $22.1M
Description
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.